Suppr超能文献

中国患者慢性肺曲霉病的临床特征与诊断

Clinical features and diagnosis of chronic pulmonary aspergillosis in Chinese patients.

作者信息

Hou Xiaomeng, Zhang Hong, Kou Lei, Lv Wei, Lu Jingjing, Li Ji

机构信息

Department of Pulmonary Medicine, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH Department of Infectious Diseases, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences Department of Radiology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences Department of Pathology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China.

出版信息

Medicine (Baltimore). 2017 Oct;96(42):e8315. doi: 10.1097/MD.0000000000008315.

Abstract

Chronic pulmonary aspergillosis (CPA) has recently been recognized as a significant global health burden. In China, the diagnosis of CPA is still unfamiliar to most doctors. The aim of this study was to demonstrate the clinical manifestations and diagnoses of CPA in China.A multidisciplinary team of doctors retrospectively screened 690 records of patients diagnosed with pulmonary aspergillosis from January 2000 to December 2016 at Peking Union Medical College Hospital, Beijing, China. Of these, 69 patients were diagnosed with CPA. The patients' clinical characteristics were then retrieved and analyzed. Demographic, laboratory, and radiological data for these patients were compared by CPA type.Of the 69 patients diagnosed with CPA, 10 patients were diagnosed with chronic cavitary pulmonary aspergillosis (CCPA), 15 patients with semi-invasive aspergillosis (SAIA), 41 patients with simple aspergilloma, and 3 patients with Aspergillus nodule. Further, 53.3% of the SAIA patients were obviously immunocompromised, and 60% of the CCPA patients, 26.7% of the SAIA patients, 7.3% of the simple aspergilloma cases were mildly immunocompromised. Previous underlying lung abnormalities were observed in 20% of CCPA patients, 53.3% of SAIA patients, and 80.5% of simple aspergilloma patients. The most common symptoms in the CPA patients were cough (92.8%), hemoptysis (63.8%), chronic sputum (23.2%), and fever (17.4%). The most common computerized tomography abnormalities were cavities (94.2%), nodule (84.1%), consolidation (4.3%), pleural thickening (2.9%), and infiltration (2.9%). CCPA, SAIA and simple aspergilloma patients were significantly different with respect to their course before diagnosis, constitutional symptoms, fever, hemoptysis, breathlessness, white blood cell count, erythrocyte sedimentation rate, high-sensitivity C-reactive protein count, presence of nodule, and presence of a solitary lesion (all P < .05). Furthermore, SAIA patients had a significantly shorter course before diagnosis and a significantly higher white blood cell count compared with CCPA patients (both P < .01).In China, underlying systemic immunocompromising conditions and lung diseases with mechanical impediments contribute to CPA. Simple aspergillosis was the most common diagnosis in CPA patients. The imaging characteristics of simple aspergillosis and Aspergillus nodules were quite discriminable, while CCPA, and SAIA were similar in their clinical and radiological features. Distinguishing between CCPA and SAIA depends mainly on the physician's clinical judgment.

摘要

慢性肺曲霉病(CPA)最近已被公认为一项重大的全球健康负担。在中国,大多数医生对CPA的诊断仍不熟悉。本研究的目的是阐述中国CPA的临床表现及诊断情况。一个多学科医生团队回顾性筛查了2000年1月至2016年12月在中国北京协和医院诊断为肺曲霉病的690例患者的记录。其中,69例患者被诊断为CPA。随后检索并分析了这些患者的临床特征。通过CPA类型对这些患者的人口统计学、实验室及影像学数据进行了比较。

在69例诊断为CPA的患者中,10例被诊断为慢性空洞型肺曲霉病(CCPA),15例为半侵袭性曲霉病(SAIA),41例为单纯曲霉球,3例为曲霉结节。此外,SAIA患者中有53.3%存在明显免疫功能低下,CCPA患者中有60%、SAIA患者中有26.7%、单纯曲霉球病例中有7.3%存在轻度免疫功能低下。20%的CCPA患者、53.3%的SAIA患者和80.5%的单纯曲霉球患者既往存在潜在肺部异常。CPA患者最常见的症状为咳嗽(92.8%)、咯血(63.8%)、慢性咳痰(23.2%)和发热(17.4%)。最常见的计算机断层扫描异常为空洞(94.2%)、结节(84.1%)、实变(4.3%)、胸膜增厚(2.9%)和浸润(2.9%)。CCPA、SAIA和单纯曲霉球患者在诊断前病程、全身症状、发热、咯血、气促、白细胞计数、红细胞沉降率、高敏C反应蛋白计数、结节存在情况及孤立性病变存在情况方面均存在显著差异(均P<0.05)。此外,与CCPA患者相比,SAIA患者诊断前病程显著更短,白细胞计数显著更高(均P<0.01)。

在中国,潜在的全身性免疫功能低下状况及伴有机械性阻碍的肺部疾病与CPA有关。单纯曲霉病是CPA患者中最常见的诊断类型。单纯曲霉病和曲霉结节的影像学特征有明显差异,而CCPA和SAIA在临床及影像学特征方面相似。区分CCPA和SAIA主要取决于医生的临床判断。

相似文献

1
Clinical features and diagnosis of chronic pulmonary aspergillosis in Chinese patients.
Medicine (Baltimore). 2017 Oct;96(42):e8315. doi: 10.1097/MD.0000000000008315.
2
Clinical features and outcome of patients with chronic pulmonary aspergillosis in China: A retrospective, observational study.
J Mycol Med. 2020 Dec;30(4):101041. doi: 10.1016/j.mycmed.2020.101041. Epub 2020 Aug 28.
3
Clinical Features, Diagnostic Test Performance, and Prognosis in Different Subtypes of Chronic Pulmonary Aspergillosis.
Front Med (Lausanne). 2022 Feb 11;9:811807. doi: 10.3389/fmed.2022.811807. eCollection 2022.
5
Chronic pulmonary aspergillosis in a tertiary care centre in Spain: A retrospective, observational study.
Mycoses. 2019 Sep;62(9):765-772. doi: 10.1111/myc.12950. Epub 2019 Jun 25.
6
Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management.
Eur Respir J. 2016 Jan;47(1):45-68. doi: 10.1183/13993003.00583-2015.
7
[A clinican linical analysis of 29 cases of chronic pulmonary aspergillosis].
Zhonghua Jie He He Hu Xi Za Zhi. 2018 Feb 12;41(2):100-104. doi: 10.3760/cma.j.issn.1001-0939.2018.02.006.
8
Diagnostic Laboratory Features and Performance of an IgG Lateral Flow Assay in a Chronic Pulmonary Aspergillosis Cohort.
Microbiol Spectr. 2023 Jun 15;11(3):e0026423. doi: 10.1128/spectrum.00264-23. Epub 2023 May 1.
9
Pathogenesis and clinical features of chronic pulmonary aspergillosis - is it possible to distinguish CNPA and CCPA clinically?
J Infect Chemother. 2014 Mar;20(3):208-12. doi: 10.1016/j.jiac.2013.10.016. Epub 2013 Dec 11.
10
[Expert consensus on the diagnosis and treatment of pulmonary aspergillosis in patients with chronic obstructive pulmonary disease].
Zhonghua Jie He He Hu Xi Za Zhi. 2024 Jul 12;47(7):604-622. doi: 10.3760/cma.j.cn112147-20231228-00399.

引用本文的文献

2
Chronic pulmonary aspergillosis: comprehensive insights into epidemiology, treatment, and unresolved challenges.
Ther Adv Infect Dis. 2024 Jun 18;11:20499361241253751. doi: 10.1177/20499361241253751. eCollection 2024 Jan-Dec.
3
Distribution of species and risk factors for aspergillosis in mainland China: a systematic review.
Ther Adv Infect Dis. 2024 Jun 4;11:20499361241252537. doi: 10.1177/20499361241252537. eCollection 2024 Jan-Dec.
4
Improved diagnostic markers for invasive pulmonary aspergillosis in COPD patients.
Front Cell Infect Microbiol. 2024 Apr 3;14:1294971. doi: 10.3389/fcimb.2024.1294971. eCollection 2024.
5
Uncovering the diversity of pathogenic invaders: insights into protozoa, fungi, and worm infections.
Front Microbiol. 2024 Mar 25;15:1374438. doi: 10.3389/fmicb.2024.1374438. eCollection 2024.
6
Diagnosis of Chronic Pulmonary Aspergillosis: Clinical, Radiological or Laboratory?
J Fungi (Basel). 2023 Nov 6;9(11):1084. doi: 10.3390/jof9111084.
7
Epidemiology and antifungal susceptibilities of clinically isolated species in South China.
Epidemiol Infect. 2023 Oct 17;151:e184. doi: 10.1017/S095026882300167X.
9
The clinical spectrum of aspergillosis in chronic obstructive pulmonary disease.
Infection. 2023 Aug;51(4):813-829. doi: 10.1007/s15010-022-01960-2. Epub 2023 Jan 20.

本文引用的文献

1
Galactomannan in bronchoalveolar lavage fluid for diagnosis of invasive aspergillosis in non-hematological patients.
J Infect. 2016 Jun;72(6):738-744. doi: 10.1016/j.jinf.2016.02.019. Epub 2016 Mar 26.
2
Recent advances in chronic pulmonary aspergillosis.
Respir Investig. 2016 Mar;54(2):85-91. doi: 10.1016/j.resinv.2015.10.003. Epub 2015 Dec 10.
3
Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management.
Eur Respir J. 2016 Jan;47(1):45-68. doi: 10.1183/13993003.00583-2015.
4
Antibody testing in aspergillosis--quo vadis?
Med Mycol. 2015 Jun;53(5):417-39. doi: 10.1093/mmy/myv020. Epub 2015 May 14.
5
Chronic Aspergillosis of the Lungs: Unravelling the Terminology and Radiology.
Eur Radiol. 2015 Oct;25(10):3100-7. doi: 10.1007/s00330-015-3690-7. Epub 2015 Mar 20.
6
Diagnosis and treatment of pulmonary aspergillosis syndromes.
Chest. 2014 Nov;146(5):1358-1368. doi: 10.1378/chest.14-0917.
7
The clinical spectrum of pulmonary aspergillosis.
Thorax. 2015 Mar;70(3):270-7. doi: 10.1136/thoraxjnl-2014-206291. Epub 2014 Oct 29.
8
Pathogenesis and clinical features of chronic pulmonary aspergillosis - is it possible to distinguish CNPA and CCPA clinically?
J Infect Chemother. 2014 Mar;20(3):208-12. doi: 10.1016/j.jiac.2013.10.016. Epub 2013 Dec 11.
9
Chronic pulmonary aspergillosis.
Mycoses. 2014 May;57(5):257-70. doi: 10.1111/myc.12152. Epub 2013 Dec 2.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验